Centessa Pharmaceuticals plc ($CNTA)
Filing Information
| Accession Number | 0001470831-26-000291 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 18, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
224,433
Total Value
$2,409,171.69
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief People Officer | Ordinary Shares | โ | Mar 16, 2026 | Exercise/Conversion | 64,768 | $4.01 | $259,719.68 | 126,853 | Direct | โ | View Details | |
Chief People Officer | Ordinary Shares | โ | Mar 16, 2026 | Sale | 64,768 | $28.21 | $1,826,969.27 | 62,085 | Direct | โ | View Details | |
Chief People Officer | Ordinary Shares | โ | Mar 17, 2026 | Exercise/Conversion | 10,043 | $4.01 | $40,272.43 | 72,128 | Direct | โ | View Details | |
Chief People Officer | Ordinary Shares | โ | Mar 17, 2026 | Sale | 10,043 | $28.10 | $282,210.31 | 62,085 | Direct | โ | View Details | |
Chief People Officer | Share Option (right to buy) | Derivative | Mar 16, 2026 | Exercise/Conversion | 64,768 | $0.00 | $0.00 | 85,043 | Direct | โ | View Details | |
Chief People Officer | Share Option (right to buy) | Derivative | Mar 17, 2026 | Exercise/Conversion | 10,043 | $0.00 | $0.00 | 75,000 | Direct | โ | View Details |